ReviewEuropean cardiology2024

Evaluating Renal Benefits of Rivaroxaban Versus Vitamin K Antagonists in Atrial Fibrillation: A Systematic Review and Meta-analysis of Real-world Evidence.

Phong Phan Dinh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.